The Division proposes to adopt and incorporate the division’s permitting application forms into rule.

 

DEPARTMENT OF BUSINESS AND PROFESSIONAL REGULATION

Drugs, Devices and Cosmetics

RULE NO.:RULE TITLE:

61N-2.011Application for Nonresident Prescription Drug Manufacturer Permit

PURPOSE AND EFFECT: The Division proposes to adopt and incorporate the division’s permitting application forms into rule.

SUMMARY: The proposed rule adopts and incorporates the division’s permitting application for nonresident prescription drug manufacturers.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:

The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: the economic review conducted by the agency.

Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

RULEMAKING AUTHORITY: 499.01, 499.012, 499.0121, 499.04, 499.041, 499.05 FS.

LAW IMPLEMENTED: 499.01, 499.01, 499.012, 499.0121, 499.015, 499.04, 499.041, 499.05, 559.79 FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Dinah Greene, Operations Review Specialist, Division of Drugs, Devices and Cosmetics, Department of Business and Professional Regulation, 2601 Blair Stone Road, Tallahassee, Florida 32399-1047; [phone]; [e-mail].

 

THE FULL TEXT OF THE PROPOSED RULE IS:

 

61N-2.011 Application for Nonresident Prescription Drug Manufacturer Permit.

A nonresident prescription drug manufacturer permit is required for any person, located outside of Florida, that is a manufacturer of a prescription drug and that engages in the distribution of such prescription drug into Florida.  A person engaging in activity for which a nonresident prescription drug manufacturer permit is required, must file an application on form number DBPR-DDC-202, Application for Permit as a Nonresident Prescription Drug Manufacturer, effective February 2017, adopted and incorporated herein by reference and comply with all the requirements for permitting in Chapter 499, F.S. and Rule Title 61N, F.A.C.  This form is available upon request from the Division of Drugs, Devices and Cosmetics at 2601 Blair Stone Road, Tallahassee, Florida 32399-1047, [phone], or at http://www.flrules.org/Gateway/reference.asp?No=Ref-07912 .

Rulemaking Authority 499.01, 499.012, 499.0121, 499.04, 499.041, 499.05 FS. Law Implemented 499.01, 499.012, 499.0121, 499.015, 499.04, 499.041, 499.05, 559.79 FS. History‒New ­­­______.

 

NAME OF PERSON ORIGINATING PROPOSED RULE: Reginald D. Dixon, Director

NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Matilde Miller, Secretary

DATE PROPOSED RULE APPROVED BY AGENCY HEAD: January 23, 2017

DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: February 26, 2016